Advertisement

Article

Elsevier Launches Next Generation Codifa, Providing Italian Doctors with Real Time Access to Critical Drug Information

PR Newswire

MILAN, August 3, 2011

MILAN , August 3, 2011 /PRNewswire/ —

Codifa Enables Italian Professionals to Take Better Decisions in a Shorter Time

Elsevier, the world-leading global provider of scientific, technical, and medical information products and services, announced today a new release of Codifa (http://www.codifa.it), an easy to use and powerful online point of care drug information platform serving Italian healthcare providers.

“We are delighted to provide real time access to critical data on drugs, tailored to a specific clinical setting and patient's needs,” said Emile Blomme , Managing Director, Elsevier Italy. “Codifa will greatly improve the appropriateness of care, help reduce risk, optimize operating costs and ultimately diminish malpractice liability.”

This project is part of Elsevier's continuous efforts to offer most qualified and relevant international contents to its local or multi-language clinical products in Europe . Codifa's critical drug information reduces the clinical risk associated with errors in prescribing or administering drugs, adverse reactions and suboptimal dosages.

The new Codifa system improves significantly the core functionalities and contents of the 2005 release, providing a new user-friendly interface and search engine designed to enhance and speed up information retrieval, reading, integration in workflows and use on handheld devices. Longstanding partnerships with important, Italian and international, institutions and associations (both public and private) ensure that Codifa provides authoritative, information on drug interactions, global brand name conversion, generic drug search and price trends.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam , Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Ludovico Baldessin
Digital Business Solutions Director, Elsevier
+39-02-88184-354

SOURCE Elsevier

0 comments on “Elsevier Launches Next Generation Codifa, Providing Italian Doctors with Real Time Access to Critical Drug Information

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.